PRL-3 Inhibitor

• CAT Number: I011769
• CAS Number: 893449-38-2
• Molecular Formula: C₁₇H₁₁Br₂NO₂S₂
• Molecular Weight: 485.21
• Purity: ≥95%
• Synonyms: 5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylene]-2-thioxo-4-thiazolidinone
• Target: Phosphatase
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: (5Z)-5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
• InChI: InChI=1S/C17H11Br2NO2S2/c18-12-5-6-14(22-9-10-3-1-2-4-13(10)19)11(7-12)8-15-16(21)20-17(23)24-15/h1-8H,9H2,(H,20,21,23)/b15-8+
• InChIKey: HXNBAOLVPAWYLT-OVCLIPMQSA-N
• SMILES: C1=CC=C(C(=C1)COC2=C(C=C(C=C2)Br)C=C3C(=O)NC(=S)S3)Br

PRL-3 Inhibitor (Cat.No:I011769) is a chemical compound designed to target and inhibit the enzyme phosphatase of regenerating liver-3 (PRL-3). PRL-3 is implicated in cancer progression and metastasis. The inhibitor shows potential in blocking PRL-3’s activity, contributing to the development of targeted therapies for certain aggressive cancers.